Nih Feels Multiplying Effects Of Government Shutdown
Tuesday 1 October should have been an exciting day for David Johnson. The biotech chief executive planned to withdraw some of the cash from a US$1.2-million small business grant that his firm, GigaGen in San Francisco, California, had been awarded just days before by the US National Institutes of Health (NIH). But Johnson was not able to access the money, nor may he be able to until the deeply divided US Congress agrees on a plan to fund government operations for the fiscal year that began on 1 October....